Abiopharma

News list

Weigensberg Arye 🟡 adjusted position in 0 shares (1 derivative) of Cronos Group Inc. (CRON) Transaction Date: May 10, 2026 | Filing ID: 000007

Full text

News bot May 12, 2026, 9:21 p.m.
🔍 Weigensberg Arye (Executive)

Company: Cronos Group Inc. (CRON)

Report Date: 2026-05-10
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 3,118
- Total shares sold: 3,118
Detailed Transactions and Holdings:
- Acquired 3,118 shares of COMMON SHARES (Direct)
  Date: 2026-05-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 211,555.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 3,118 shares of RESTRICTED STOCK UNITS (Derivative)
  Date: 2026-05-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 154,419.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each restricted stock unit ("RSU") represents a contingent right to receive one common share of Cronos Group Inc.
- F2: On May 10, 2024, the reporting person was granted 9,355 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
- REMARKS: Senior Vice President, Head of Research and Development